The long term goals of the Developmental Core are to solicit and provide funding for novel research? projects of HIV research from our three member institutions (FHI, RTI, UNC) as well as our minority partners? (within the UNC system, such as North Carolina Central University, Pembroke, UNC-Greensboro, etc., and? outside, such as the University of Puerto Rico). We shall conduct objective peer review and assign senior? investigators as mentors to nurture the research, publication and grant submission. In the first year of the? new grant cycle we shall combine $150,000 of CFAR funds with $65,000 of UNC funds to support one to two? year small ($5,000-$20,000) awards in all aspects of HIV research (basic and clinical sciences, translational? research, epidemiology, vaccines, and behavioral research). We shall continue to focus on the ongoing? epidemic in women, minorities, and international communities. In addition to our annual RFP, we shall set? aside funds for directed research on emerging problems identified by Core Directors. Outreach and? education will be accomplished through 1) presentation by Awardees at our weekly conference, 2) annual? visits to HMUs on World AIDS Day with didactic talks for students and faculty and solicitation of collaborative? research projects, 3) our annual HIV Update course for 400 clinicians from the Southeast, 4) our annual? World AIDS Day Symposium at UNC for RTI, UNC and FHI, 5) our annual Community Forum reviewing new? information for clients, and 6) a university-wide course on AIDS attended by 250 annually. Promising? minority junior investigators will be identified and mentored until they have successful independent careers.? Continuous quality improvement will remain a focus consisting of a review of the entire process including? solicitation, review, mentoring and productivity of Awardees.? The CFAR Developmental Core has awarded 85 small grants since its inception, of which 11 are still in? progress or in data analysis. Developmental research has resulted in: 55 outside grants, with six more? currently in review; one patent; 64 papers, with 17 more either in press or under review; one free statistical? package available on-line; and 71 presentations at national and international conferences. Developmental? Awardees have already received a total of over $50,000,000 in subsequent funding.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI050410-11
Application #
7644963
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2008-06-01
Project End
2011-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
11
Fiscal Year
2008
Total Cost
$315,761
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Lancaster, Kathryn E; Hoffman, Irving F; Hanscom, Brett et al. (2018) Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis. J Int AIDS Soc 21:e25195
Honeycutt, Jenna B; Liao, Baolin; Nixon, Christopher C et al. (2018) T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest 128:2862-2876
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187
Henderson, Gail E; Peay, Holly L; Kroon, Eugene et al. (2018) Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment. J Med Ethics 44:270-276
Hanson, Erik D; Danson, Eli; Evans, William S et al. (2018) Exercise Increases MAIT Cell Cytokine Expression but not Activation or Homing Markers. Med Sci Sports Exerc :
Gopal, Satish; Gross, Thomas G (2018) How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa. Blood 132:254-263
Horner, Marie-Josèphe; Salima, Ande; Chilima, Chrissie et al. (2018) Frequent HIV and Young Age Among Individuals With Diverse Cancers at a National Teaching Hospital in Malawi. J Glob Oncol :1-11
Howe, Chanelle J; Dulin-Keita, Akilah; Cole, Stephen R et al. (2018) Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework. Am J Epidemiol 187:316-325
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372

Showing the most recent 10 out of 1688 publications